ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

QGEN Qiagen NV

41.65
0.57 (1.39%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Qiagen NV QGEN NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.57 1.39% 41.65 09:00:00
개장가 저가 고가 종가 전일 종가
41.10 41.06 41.68 41.65 41.08
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:05GLOBEQIAGEN expands tuberculosis portfolio with new NGS Panel to..
09/04/202422:48GLOBEQIAGEN N.V. to release results for Q1 2024 and hold webcast
04/04/202405:05GLOBEQIAGEN strengthens its portfolio for cancer research,..
26/03/202405:05GLOBEQIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test..
19/03/202405:05GLOBEQIAGEN partners with International Panel Physicians..
11/03/202418:59GLOBEQIAGEN announces Form 20-F annual report filing for 2023..
28/02/202407:44GLOBEQIAGEN launches AI-derived biomedical knowledge base to..
28/02/202406:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
16/02/202406:05GLOBEQIAGEN earns ACT Label for new eco-friendlier QIAwave..
08/02/202423:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/02/202406:05GLOBEQIAGEN exceeds outlook for Q4 2023, led by 8% CER sales..
26/01/202400:00GLOBEQIAGEN announces partnership with Penn State University to..
24/01/202406:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/01/202406:05GLOBEQIAGEN announces details for completion of synthetic share..
11/01/202421:53GLOBEQIAGEN N.V. to release results for Q4 2023 and hold webcast
08/01/202423:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202416:00GLOBEQIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use..
08/01/202403:07GLOBEQIAGEN announces plans to return approximately $300 million..
05/01/202406:05GLOBEQIAGEN to accelerate investments into QIAGEN Digital..
03/01/202416:00GLOBEQIAGEN expands business in Middle East with new regional..
01/12/202306:05GLOBEDNA Labs International solves significant cold cases with..
16/11/202306:05GLOBEQIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro..
10/11/202306:05GLOBEQIAGEN launches new QIAcuity digital PCR kits and updated..
07/11/202306:05GLOBEQIAGEN launches complete Sample to Insight workflow for..
02/11/202321:00PRNUSQIAGEN and Element Biosciences partner to offer complete..
31/10/202305:05GLOBEQIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth..
26/10/202321:00GLOBEQIAGEN and Myriad Genetics partner to advance companion..
10/10/202300:14GLOBEQIAGEN N.V. to release results for Q3 2023 and hold webcast
05/10/202305:05GLOBEQIAGEN launches QuantiFERON-EBV RUO assay, facilitating..
29/09/202305:05GLOBEQIAGEN extends AI capabilities of its NGS interpretation..
28/09/202305:05GLOBEQIAGEN reports progress toward achieving Environmental,..
26/09/202305:05GLOBEQIAGEN enhances QIAwave portfolio with new eco-friendlier..
26/08/202305:48EDGAR2Form 144 - Report of proposed sale of securities
10/08/202310:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/08/202310:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/08/202305:05GLOBEQIAGEN delivers ahead of outlook for Q2 2023 with 9% CER..
08/08/202305:05GLOBEQIAGEN receives FDA approval for companion diagnostic to..
27/07/202305:15GLOBEBio-Rad and QIAGEN announce patent settlement and..
24/07/202320:41GLOBEQIAGEN N.V. to release results for Q2 2023 and hold webcast
19/07/202305:05GLOBEQIAGEN expands range of digital PCR kits and services for..
21/06/202305:05GLOBEFBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow..
16/06/202320:36GLOBEQIAGEN provides reminder on settlement mechanics of 2023 and..
16/06/202305:05GLOBEQIAGEN’s QuantiFERON-TB Gold Plus shows unique clinical..
14/06/202305:05GLOBEDanish National Genome Center selects QIAGEN for variant..
04/05/202305:05GLOBEQIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth..
03/05/202318:30GLOBEQIAGEN welcomes U.S. Preventive Services Task Force..

최근 히스토리

Delayed Upgrade Clock